Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
82,051,282
-
Total 13F shares
-
23,259,955
-
Share change
-
+5,484,836
-
Total reported value
-
$459,848,025
-
Price per share
-
$19.77
-
Number of holders
-
52
-
Value change
-
+$113,446,724
-
Number of buys
-
35
-
Number of sells
-
9
Institutional Holders of Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN) as of Q4 2021
As of 31 Dec 2021 Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value (VRDN) had 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 23,259,955 shares of stock of the company.
Largest 10 holders included BVF INC/IL, VR Adviser, LLC, FRAZIER MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, Deep Track Capital, LP, TCG Crossover Management, LLC, Vivo Capital, LLC, Avidity Partners Management LP, Paradigm Biocapital Advisors LP, and Fairmount Funds Management LLC.
This table shows 52 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.